Use of CereGate Therapy for Freezing of Gait in PD
RecruitingNCT05292794Phase: NAStarted 2022-04-18
Summary
A Multi-Center, Controlled Study to Evaluate Use of CereGate Therapy to Reduce Freezing of Gait in Participants Diagnosed with Parkinson's Disease.
Eligibility
Sex
ALL
Min Age
21 Years
Max Age
80 Years
Locations
Kaiser Permanente, KPNC Comprehensive Movement Disorders ProRedwood City, California, United States
University of Colorado Anschutz Medical CampusAurora, Colorado, United States
University of MiamiMiami, Florida, United States
Northwestern UniversityChicago, Illinois, United States
Wake Forest UniversityWinston-Salem, North Carolina, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT05292794